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Background and Aims: Several studies have shown that host genetic factors can be 
associated with the risk of developing Helicobacter pylori infections. Therefore, we 
evaluated the most prevalent toll-like receptors (TLRs) polymorphisms in Helicobacter 
pylori positive subjects and their possible role in susceptibility to Helicobacter pylori 
infections. 
Materials and Methods: Using related keywords, an independent search in the electronic 
databases including PubMed, Scopus, Google Scholar and ISI web of knowledge was 
performed to collect studies evaluating, until January 15, 2019, polymorphisms in the 
TLR 1 to 13 genes and their association with susceptibility to Helicobacter pylori 
infection. A total of 18 articles met our inclusion criteria and thus were included in the 
meta-analysis.  
Results: In this meta-analysis, a significantly increased risk of Helicobacter pylori 
infection was observed in subjects carrying TLR2 rs3804099 (TT vs. CC: odds ratio = 
2.209, 95% CI: 1.283-3.804), TLR4 rs4986790 (A allele vs. G allele: odds ratio = 2.987, 
95% CI: 1.899-4.697), TLR4 rs4986791 (C allele vs. T allele: odds ratio = 5.469, 95% CI: 
13.432-8.713), TLR4 rs4986791 (CC vs. TT: odds ratio = 7.974, 95% CI: 2.682-23.706), 
TLR4 rs10759932 (TT vs. CC: odds ratio = 3.180, 95% CI: 1.022-9.890), TLR4 
rs1927914 (C allele vs. T allele: odds ratio = 8.831, 95% CI: 4.222-18.470), and TLR9 
rs352140 (CC vs. CT: odds ratio = 1.878, 95% CI: 1.071-3.290) polymorphisms. 
Conclusions: This meta-analysis indicated that TLR2 rs3804099, TLR4 rs4986790, TLR4 
rs4986791, TLR4 rs10759932, TLR4 rs1927914 and TLR9 rs352140 polymorphisms 
are associated with increased susceptibility to Helicobacter pylori infections. 
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Introduction 
It has been estimated that gastric mucosa of 
more than half of the world’s population is 
infected with Helicobacter pylori (H. pylori), 
ranging from 25-50% in the developed 
countries to more than even 80% in the 
developing world [1, 2]. The prevalence of 
infection in 10% of children in the 
industrialized countries and more than 50% in 
the developing countries shows that H. pylori 
infection is usually found in childhood and in 
most cases remains in the gastric mucosa  
for a lifetime unless treated [1-3]. Chronic 
inflammation in the mucosal epithelium due to 
persistent H. pylori infection is associated with 
a variety of clinical outcomes such as gastritis 
and gastric ulcers in 10–20% of the infected 
individuals, which are the most common type 
of gastric diseases related to H. pylori [3]. 
Additionally, it is well established that H. pylori 
infection, classified as category I carcinogen, 
plays a crucial role in the development of 
gastric cancer, and 1-2% of infected subjects 
develop this type of cancer [4]. In addition to 
bacterial and environmental factors that affect 
the individuals’ susceptibility to H. pylori 
infection, host factors are also important [5]. 
Several polymorphisms in the genes encoding 
inflammatory proteins, cytokines, growth 
factors, chemokines and another immune 
response genes have been identified to be 
associated with the susceptibility to H. pylori 
infection [6, 7]. Cells involved in the innate 
immunity including mucosal epithelial cells and 
myeloid cells, macrophages and dendritic cells, 
are responsible for the initial response to 
H. pylori components during infection which  
is mediated through the pattern recognition 
receptors (PRRs) such as toll-like receptors 
(TLRs). TLRs recognize preserved microbial 
structures, pathogen-dependent molecular 
patterns (PAMPs), such as flagellin, lipopoly-
saccharide (LPS) and peptidoglycan located on 
the surface of the bacteria, fungi, protozoa, and 
viruses. TLRs also recognize endogenous 
ligands such as damage-associated molecular 
patterns (DAMPs) e.g. heat shock proteins 
which are spontaneously released during cell 
stress [8]. The family of TLRs includes 13 
members in mammalians that are either located 
on the surface of the cell, such as TLRs 1, 2, 4, 
5 , 6 and 10, or are located on the endoplasmic 
reticulum membrane or on the endosomal/ 
lysosomal membrane such as TLRs 3, 7, 8 and 
9 [8-10]. The interaction of TLRs, expressed in 
most tissues and components of the envelope 
and nucleic acids of the infectious pathogen, 
results in the activation of intracellular 
signaling pathways that lead to inflammatory 
responses and activation of immune responses 
[8, 9]. Recently, several investigations have 
shown the role of genetic variations, 
including single nucleotide polymorphisms 
(SNPs), in the members of the TLR family in 
susceptibility to various infections, especially 
bacterial infections [9].  
The purpose of this systematic review and 
meta-analysis was to evaluate the most 
prevalent TLR polymorphisms in H. pylori-
positive subjects and the association of these 
polymorphisms with the susceptibility to H. 
pylori infections. 
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Materials and Methods 
Literature search strategy 
Three authors independently searched the 
electronic databases including PubMed, 
Scopus, Google Scholar and ISI web of 
knowledge to collect all case-control studies 
evaluating polymorphisms in the TLR 1 to 13 
genes and their association with susceptibility 
to H. pylori infection. The last search was 
performed on January 15, 2019 using Medical 
Subject Headings (MeSH) terms including toll-
like receptors, TLRs, polymorphisms, single-
nucleotide polymorphisms, SNPs, mutations, 
variations and H. pylori infection. Hand 
searching of reference lists of the selected 
studies was performed to find any missed 
potential relevant article. 
Study selection criteria 
Eligible articles were selected based on the 
following criteria: 1) papers published in the 
English language, 2) case-control studies; case 
samples were infected individuals with H. 
pylori (H. pylori positive) and controls were H. 
pylori uninfected (H. pylori negative), and 3) 
articles investigating polymorphisms in the 
TLR 1 to 13 genes and their association with 
susceptibility to H. pylori infection. Articles 
with the following characteristics did not meet 
our inclusion criteria and were excluded from 
the meta-analysis: 1) articles evaluating the 
association between polymorphisms in the 
TLRs genes and susceptibility to other bacterial 
infection or other diseases, 2) articles evaluating 
other gene polymorphisms or other host  
genetic factors, 3) articles not comprising 
enough information on the prevalence of 
polymorphisms in the TLRs genes, genotypes 
and allele frequencies in H. pylori positive and 
negative individuals, and 4) articles evaluating 
polymorphisms in the TLRs genes only in the 
H. pylori infected or H. pylori uninfected 
individuals. 
Data extraction 
Data from each study were extracted and 
tabulated in Table 1. Collected characteristics 
were as follows: 1) country of origin, 2) year of 
publication 3) ethnicity, 4) genotyping method, 
5) number of H. pylori positive subjects, 6) 
number of H. pylori negative subjects, 7) type 
of disease, 8) type of polymorphism, 9) H. 
pylori detection method and 10) references. 
Statistical analysis 
We performed all statistical analyses using 
Comprehensive Meta-Analysis (CMA) software 
version 2.2 (Biostat, Englewood, NJ, USA). 
Using allelic and genotypic models, the 
association between TLRs polymorphisms and 
susceptibility to H. pylori infection was 
measured by ratio (ORs) with 95% confidence 
intervals (95% CIs). When the p value was  
less than 0.05, association was statistically 
significant. Additionally, the frequency of 
polymorphisms in the TLRs genotypes/alleles 
among H. pylori infection positive case and 
control subjects was expressed as percentage 
(%). Fixed-effect model was used to pooled 
data when there was no heterogeneity and 
Cochrane Q test was statistically significant 
(I2=0–25 %, P<0.05); however, in large 
heterogeneity (I2=75–100 %, P<0.05), random 
effects model was used [11]. In the current 
meta-analysis, publication bias was evaluated 
using funnel plots. 
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Results 
Study and populations characteristics 
After comprehensive literature search in the 
electronic databases including PubMed, 
Scopus, Google Scholar and ISI web of 
knowledge until January 15, 2019, a total of 
3157 articles were collected. As shown in 
Figure 1, 18 qualified studies were included for 
final analysis after meeting the inclusion 
criteria, including 5 studies from Caucasian 
ethnicity, 3 studies from Iranian ethnicity, 2 
studies from Chinese ethnicity, 2 studies from 
Japanese ethnicity, 2 studies from Thai 
ethnicity, 1 study from Malaysian ethnicity, 1 
study from Indian ethnicity, 1 studies from 
Kashmiri ethnicity, and 1 study from Brazilian 
ethnicity. The main characteristics of included 
studies in the meta-analysis are shown in table 
1. In the present study, included studies were 
reported from China, Japan, Thailand, 
Malaysia, India, Iran, Germany, Scotland, 
Lithuania, Latvia and Brazil. Main TLRs genes 
polymorphisms in included studies which are 
more common among H. pylori infection 
positive individuals were shown in the different 
ethnicities (Table 1). Polymerase chain 
reaction (PCR)-based methods were the most 
frequent techniques used for determining  
the TLRs genotypes/alleles. Additionally, 
various studies have used different detection 
methods to identify H. pylori positive subjects. 
Patients had different H. pylori-related diseases 
including gastric cancer, non-ulcer dyspepsia, 
peptic ulcer disease, gastric atrophy, mucosa-
associated lymphoid tissue lymphoma and 
gastritis. Table 2 displays distribution of 
genotypes and allele frequencies of TLRs genes 
polymorphisms in H. pylori positive and 
negative individuals. Additionally, Table 3 
reveals association between TLRs genes 
polymorphisms, genotypes/ alleles, and 
H. pylori infection. 
Association between TLR1 polymorphisms 
with susceptibility to H. pylori infections 
In the present meta-analysis, we evaluated 
possible associations between TLR1 rs4833095 
and TLR1 rs5743618 polymorphisms with 
susceptibility to H. pylori infections (Table 2). 
The TLR1 rs4833095 variants were CC, CT 
and TT that occurred in 896 (45.8%), 687 
(35.2%) and 370 (19%) of H. pylori infection-
positive cases and in 416 (29%), 871 (60.5%) 
and 151 (10.5%) H. pylori infection-negative 
controls. Frequency of mutant genotypes, CT 
and TT, were 1057 (54.1%) and 1022 (71%) in 
H. pylori infection-positive and -negative 
individuals, respectively. In the Chinese, Thai, 
and Malaysian populations, genotype frequency 
of variant genotypes, CT and TT, were 859 
(44%), 164 (8.3%) and 34 (1.7%), respectively, 
in H. pylori infection-positive individuals,  
and 639 (44.4%), 364 (25.3%) and 19 (1.3%),  
in H. pylori infection-negative individuals, 
respectively. Overall, in the genotypic  
model, there was no significant association 
between TLR1 rs4833095 polymorphism and 
susceptibility to H. pylori infections (Table 3). 
For the TLR1 rs5743618 polymorphism, 
genotypes, II, IS and SS, were 14 (6.2%), 72 
(31.4%) and 143 (62.4%) in H. pylori infection-
positive cases and 4 (7.5%), 17 (32%) and  
32 (60.5%) in H. pylori infection-negative 
controls. Additionally, in Caucasian population, 
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frequency of mutant genotypes, IS and SS,  
were 215 (93.8%) and 49 (92.4%) in H. pylori 
infection-positive and -negative individuals, 
respectively. Such as TLR1 rs4833095 
polymorphism, there was no significant 
association between TLR1 rs5743618 
polymorphism and susceptibility to H. pylori 
infections (Table 3). 
Association between TLR2 polymorphisms 
with susceptibility to H. pylori infections 
Several studies have reported association 
between six TLR2 SNPs (-196 to -174 
(ins→del), rs3804099 (T→C), rs3804100 
(T→C), +2251 (G→A), rs121917864 
(Arg677Trp), and rs5743708 (Arg753Gln)) 
with susceptibility to H. pylori infections. 
For TLR2 -196 to -174 SNP, genotype and 
allele frequencies were as follows: ins/ins 541 
(46.2%), ins/del 504 (43.2%), del/del 124 
(10.6%), ins 345 (70.5%), and del 145 (29.5%) 
in H. pylori infection-positive individuals and 
ins/ins 376 (46%), ins/del 355 (43.6%) and 
del/del 85 (10.4%), ins 198 (72.7%), del  
74 (27.3%) in H. pylori infection-negative 
individuals. Frequency of variant allele, del, and 
variant genotypes, ins/del and del/del, in 
different populations are illustrated in table 2. 
Overall, no association was found between 
TLR2 -196 to -174 polymorphism with 
susceptibility to H. pylori infections in genotypic 
and allelic models (Table 3). For TLR2 
rs3804099 SNP, TT, TC and CC genotypes 
frequency were 126 (61.7%), 27 (13.3%), and 51 
(25%) in H. pylori infection-positive individuals 
and 131 (66.8%), 41 (21%), and 24 (12.2%)  
in H. pylori infection-negative individuals. In 
addition, genotype frequency of mutant 
heterozygote and homozygote, TC and CC, were 
78 (38.2%) and 65 (33.1%) in H. pylori 
infection-positive and -negative individuals, 
respectively. Individuals with the CC mutant 
homozygote genotype for TLR2 rs3804099 SNP 
had a significantly increased risk of H. pylori 
infection (Table 3 and Fig. 2). For TLR2 
rs3804100 SNP, TT, TC and CC genotypes 
frequency were 147 (72%), 49 (24%), and 8 
(4%) in H. pylori infection-positive individuals 
and 149 (76%), 43 (22%), and 4 (2%) in H. 
pylori infection-negative individuals. Genotype 
frequency of mutant heterozygote and 
homozygote, TC and CC, were 57 (28%) and 47 
(24%) in H. pylori infection-positive and -
negative individuals, respectively. The results 
indicated that the TLR2 rs3804100 TC and CC 
genotypes variant failed to have any association 
with increased risk of H. pylori infection in Thai 
population (Table 3). For TLR2 +2251 (G→A) 
SNP, GG, GA and AA genotypes frequency 
were 225 (99.1%), 2 (0.9%), and 0 (0%) in  
H. pylori infection-positive individuals and  
252 (98.4%), 4 (1.6%), and 0 (0%) in H. pylori 
infection-negative individuals. Genotype 
frequency of mutant genotypes, GA and AA, 
were 2 (9%) and 4 (1.6%) in H. pylori infection-
positive and -negative individuals, respectively. 
In Brazilian population, the TLR2 +2251 GG 
and GA genotypes variant did not show any 
association with increased risk of H. pylori 
infection (Table 3).  
Association between TLR4 polymorphisms 
with susceptibility to H. pylori infections 
In the current meta-analysis, association 
between five TLR4 SNPs (rs4986790, 
rs4986791, rs11536889, rs10759932, and 
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rs1927914) with susceptibility to H. pylori 
infections was evaluated. For TLR4 rs4986790 
SNP, frequency of genotypes amounted to AA 
1104 (84.5%), AG 192 (14.7%) and GG 9 (0.8 
%) in H. pylori infection-positive cases and 981 
(85.5%), 157 (13.6%) and 9 (0.9 %) in H. pylori 
infection-negative controls. Frequency of 
mutant genotypes, AG and GG, were 201 
(15.4%) and 166 (14.4%) in H. pylori infection-
positive and -negative individuals, respectively. 
Additionally, frequency of mutant allele, G, 
was 45 (17%) and 47 (8.5%) in H. pylori 
infection-positive and -negative individuals, 
respectively. Overall, no association was found 
between TLR4 rs4986790 polymorphism  
with susceptibility to H. pylori infections in 
genotypic model; however, there was a 
significant association in allelic model (Table 3 
and Figure 2). For TLR4 rs4986791 SNP, CC, 
CT and TT genotypes frequency were 131 
(72.4%), 41 (22.6%), and 9 (5%) in H. pylori 
infection-positive individuals and 223 (87.1%), 
27 (10.5%), and 6 (2.4%) in H. pylori infection-
negative individuals. Frequency of variant 
allele, T, and variant genotypes, CT and TT, 
were as follows: 57 (21.4%), and 50 (27.6%) in 
H. pylori infection-positive individuals, and 36 
(6.5%), and 33 (12.8%) in H. pylori infection-
negative individuals. Both mutant homozygote 
genotype, TT, and mutant allele, T, have shown 
highly significant association with susceptibility 
to H. pylori infections (Table 3 and Fig. 2). 
For TLR4 rs11536889 SNP, GG, GC and CC 
genotypes frequency were 1016 (59.4%), 587 
(34.2%), and 109 (6.4%) in H. pylori infection-
positive individuals and 431 (59.8%), 242 
(33.6%), and 47 (6.6%) in H. pylori infection-
negative individuals. Also, G and C alleles 
frequency were 984 (85%) and 170 (15%) in H. 
pylori infection-positive individuals and 614 
(85%) and 112 (15%) in H. pylori infection-
negative individuals. Frequency of variant 
allele, C, and variant genotypes, GC and CC, 
were as follows: 170 (14.7%) and 696 (40.6%) 
in H. pylori infection-positive individuals, and 
112 (15.4%) and 289 (40.1%) in H. pylori 
infection-negative individuals. Overall, no 
association was found between TLR4 
rs11536889 polymorphism with susceptibility 
to H. pylori infections in genotypic and allelic 
models (Table 3). For TLR4 rs10759932 SNP, 
TT, TC and CC genotypes frequency leveled at 
153 (75%), 37 (18.2%), and 14 (6.8%) in H. 
pylori infection-positive individuals and 139 
(71%), 53 (27%), and 4 (2%) in H. pylori 
infection-negative individuals. We found a 
significant association between TLR4 
rs10759932 CC mutant genotype with 
susceptibility to H. pylori infections (Table 3 
and Fig. 2). Our results revealed a significant 
association between TLR4 rs1927914 T mutant 
allele with susceptibility to H. pylori infections 
(Table 3 and Figure 2). 
Association between TLR5 polymorphisms 
with susceptibility to H. pylori infections 
Among four TLR5 SNPs (rs5744174, 
rs5744168, rs1640827 and rs17163737) which 
were evaluated in terms of their susceptibility to 
H. pylori infections, only one polymorphism, 
TLR5 rs5744168, yielded enough information. 
Genotype frequency of CC, CT, and TT were 
206 (91.6%), 19 (8.4%), 0 (0%) in H. pylori 
infection-positive individuals and 239 (93.7%), 
16 (6.3%), and 0 (0%) in H. pylori infection-
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negative individuals. Frequency of variant 
genotypes, CT and TT, were 19 (8.4%) in  
H. pylori infection-positive individuals, and  
16 (6.2%) in H. pylori infection-negative 
individuals. Overall, no association was found 
between TLR5 rs5744168 polymorphism  
and susceptibility to H. pylori infections in 
genotypic model (Table 3). 
Association between TLR9 polymorphisms 
with susceptibility to H. pylori infections 
We evaluated the role of four TLR9 SNPs 
(rs352140, rs34399053, rs150459369 and 
rs5743836) in susceptibility to H. pylori 
infections. For TLR9 rs352140 SNP, genotype 
frequency of CC, CT, and TT were 25 (32.5%), 
46 (59.7%), and 6 (7.8%) in H. pylori infection-
positive individuals and 100 (43.4%), 98 
(42.6%), and 32 (14%) in H. pylori infection-
negative individuals. In addition, C and T 
alleles frequencies were 96 (62.3%) and 58 
(37.7%), in H. pylori infection-positive 
individuals and 298 (64.8%) and 162 (35.2%) 
in H. pylori infection-negative individuals. 
Frequency of variant allele, T, and variant 
genotypes, CT and TT reached as follows: 58 
(37.7%) and 52 (67.5%) in H. pylori infection-
positive individuals, and 162 (35.2%) and  
130 (56.5%) in H. pylori infection-negative 
individuals. Our results demonstrated a 
significant association between TLR9 rs352140 
CT mutant genotype with susceptibility to H. 
pylori infections (Table 3 and Fig. 2). 
For TLR9 rs34399053 SNP, genotype 
frequency of CC, CT, and TT were 26 (33.7%), 
51 (66.3%), and 0 (0%) in H. pylori infection-
positive individuals and 79 (34.3%), 150 
(65.2%), and 1 (0.5 %) in H. pylori infection-
negative individuals. Frequency of variant 
allele, T, and variant genotypes, CT and TT, 
were as follows: 51 (33.2%) and 51 (66.3%) in 
H. pylori infection-positive individuals, and 152 
(33%) and 151 (65.6%) in H. pylori infection-
negative individuals. On balance, no association 
was found between TLR9 rs34399053 
polymorphism with susceptibility to H. pylori 
infections in allelic and genotypic models 
(Table 3). For TLR9 rs150459369 SNP, CC, 
CT, and TT genotypes frequency were 77 
(100%), 0 (0%), and 0 (0%) in H. pylori 
infection-positive individuals and 220 (95.6%), 
10 (4.4%), and 0 (%) in H. pylori infection-
negative individuals. In addition, C and T 
alleles frequency were 154 (100%) and 0 (0 %) 
in H. pylori infection-positive individuals and 
450 (97.8%) and 10 (2.2%) in H. pylori 
infection-negative individuals. Frequency of 
variant allele, T, and variant genotypes, CT and 
TT, were as follows: 0 (0%) and 0 (0%) in  
H. pylori infection-positive individuals, and 10 
(2.2%) and 10 (4.4%) in H. pylori infection-
negative individuals. By and lange, no 
association was found between TLR9 
rs150459369 polymorphism with susceptibility 
to H. pylori infections in allelic and genotypic 
models (Table 3). For TLR9 rs5743836 SNP, 
TT, TC and CC genotypes frequencies were 77 
(65.8%), 40 (34.2%), and 0 (0%) in H. pylori 
infection-positive individuals and 35 (68.6%), 
15 (29.5%), and 1 (1.9%) in H. pylori infection-
negative individuals. Overall, no association 
was detected between TLR9 rs5743836 
polymorphism with susceptibility to H. pylori 
infections in allelic and genotypic models 
(Table 3). 
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Association between TLR10 polymorphisms 
with susceptibility to H. pylori infections 
The role of two polymorphisms, TLR10 
rs10004195 and TLR10 rs4129009, in 
susceptibility to H. pylori infections were 
determined. For TLR10 rs10004195 SNP, AA, 
AT and TT genotypes frequency were 581 
(33.3%), 740 (42.3%), and 426 (24.4%) in  
H. pylori infection-positive individuals and 339 
(27.5%), 627 (51%), and 266 (21.5%)  
in H. pylori infection-negative individuals. 
Additionally, frequencies of variant genotypes, 
AT and TT, were as follows: 1166 (66.7%) and 
893 (72.4%) in H. pylori infection-positive and 
-negative individuals, respectively. All in all, no 
association was found between TLR10 
rs10004195 polymorphism with susceptibility 
to H. pylori infections in genotypic model 
(Table 3). Frequency of variant genotypes, TC 
and CC, were as follows: 990 (66.1%) and 667 
(65.5%) in H. pylori infection-positive and -
negative individuals, respectively. Totally, 
no association was found between TLR10 
rs4129009 polymorphism with susceptibility 
to H. pylori infections in genotypic model 
(Table 3). 
Finally, no study was found in terms of 
evaluating association between TLR3, 6-8, 11-
13 and susceptibility to H. pylori infections. 
 
 
Fig. 1. Flowchart of eligible studies selection process in the meta-analysis 
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Fig. 2. Forest plot of the meta-analysis on the association between TLR2 rs3804099, TLR4 rs4986790, TLR4 
rs4986791, TLR4 rs10759932, TLR4 rs1927914, and TLR9 rs352140 and susceptibility to H. pylori 
infections. 
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Table 1. The main data of included studies in the meta-analysis 
Country 
Genotyping 
method 
H. pylori 
positive 
(N) 
H. pylori 
negative 
(N) 
Total 
(N) 
Disease 
type 
Polymorphism 
H. pylori 
detection method 
Ref. 
China 
Real-time 
PCR 
1511 1042 2553 
GA 
 DYS 
IM 
 SG 
TLR1 rs4833095 
TLR10 rs10004195 
TLR10 rs4129009 
13C-UBT 12 
China 
Real-time 
PCR  
Mass 
spectrometry 
190 94 284 GC 
TLR2 -196 to -174 
del 
TLR4 rs11536889 
Serum anti-
H. pylori 
IgG antibody 
13 
Japan PCR 937 699 1636 GA 
TLR2 -196 to -174 
del 
Serum anti-H. 
pylori 
IgG antibody 
14 
Japan PCR-CTPP 1191 401 1592 GA TLR4 rs11536889 
Serum anti- 
H. pylori 
IgG 
antibody 
15 
Thailand 
Real-time 
PCR 
204 196 400 
GC 
Gastritis 
 
TLR1 rs4833095 
TLR2 rs3804099 
TLR2 rs3804100 
TLR4 rs10759932 
TLR10 rs10004195 
Histopathologic
al examination 
Real-time PCR 
16 
Thailand 
Real-time 
PCR 
204 196 400 Gastritis TLR1 rs4833095 
Histopathological 
examination 
17 
Malaysia 
Real-time 
PCR 
62 33 95 
GC 
NUD 
PUD 
TLR1 rs4833095 
TLR10 rs10004195 
RUT Culture 
Histopathological 
examination 
18 
India 
PCR-RFLP 
ARMS-PCR 
77 230 307 PUD 
TLR4 rs1927914 
TLR4 rs4986790 
TLR4 rs4986791 
TLR9 rs352140 
TLR9 rs34399053  
TLR9 rs150459369 
 
RUT 19 
India PCR-RFLP 104 26 130 GC 
TLR4 rs4986790 
TLR4 rs4986791 
 
PCR (glmM) 20 
Iran 
ASPCR 
PCR-RFLP 
 
55 45 100 PUD 
TLR2 -196 to -174 
ins/del 
TLR2 rs121917864  
TLR2 rs5743708 
RUT 
Serum anti-H. 
pylori IgG 
antibody 
Histopathological 
examination 
PCR (glmM) 
21 
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Iran 
PCR–CTPP 
PCR-RFLP 
56 44 100 PUD 
TLR4 rs11536889 
TLR4 rs4986790 
TLR4 rs4986791 
 
RUT 
Histopathological 
examination 
Serum anti-
H. pylori 
IgG antibody 
22 
Iran PCR-RFLP 195 241 436 Gastritis TLR4 rs4986790 
RUT 
PCR (16s rRNA 
and glmM) 
*Histological 
examination 
23 
Scotland 
Applied 
Biosystems 
5 nuclease 
SNP 
genotyping 
assay 
117 51 168 GA TLR9 rs5743836 
14C-UBT 
Serology 
RUT 
Culture 
Histopathological 
examination 
24 
Scotland 
PCR-RFLP 
Real-time 
PCR 
103 46 149 GC TLR4 rs4986790 
14C-UBT 
Serology 
RUT 
Culture 
Histopathological 
examination 
25 
Germany 
Fluorescence-
labeled 
hybridization 
FRET probes 
229 53 548 
GC 
HRG 
TLR1 rs5743618 
Serum anti-
H. pylori 
IgG antibody 
26 
Germany 
Real-time 
PCR 
594 358 952 
MALT 
lympho
ma 
TLR4 rs4986790 
RUT 
and 
Histopathological 
examination 
27 
Germany 
Lithuania 
Latvia 
PCR-RFLP 203 97  
GC 
GA 
TLR4 rs11536889 
Serum anti-
H. pylori 
IgG antibody 
28 
Brazil PCR-RFLP 232 254 486 
Duoden
al ulcer 
Gastritis 
TLR2 (+2251) 
TLR4 rs4986790 
TLR5 rs5744168 
13C-UBT 
Culture 
RUT 
PCR (urea) 
29 
MALDI-TOF= Matrix assisted laser desorption ionization time-of-flight; ELISA= Enzyme-linked immunosorbent 
assay; PCR-RFLP= Polymerase chain reaction-restriction fragment length polymorphism; PCR-CTPP= 
Polymerase chain reaction with confronting two-pair primers, ASPCR= Allele-specific polymerase chain reaction; 
HPLC= High-performance liquid chromatography; 13C- and 14C-UBT= 13C- and 14C-urea breath test; RUT= Rapid 
urease test; GC= Gastric cancer, NUD= Non-ulcer dyspepsia; PUD= Peptic ulcer disease; GA= Gastric atrophy, 
MALT= Mucosa-associated lymphoid tissue lymphoma; HRG= High-risk gastritis, DYS=; Dysplasia; IM= 
intestinal metaplasia; SG= Superficial gastritis; NA= Not available. 
*Histopathological examination: H & E and Giemsa staining.  
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Table 2. Distribution of genotype and allele frequencies of polymorphisms in the TLRs genes in H. pylori 
positive and negative individuals 
 
 
TLR 
 
 
Variant 
 
 
SNP 
number 
H. pylori infection 
positive  
(N) 
H. pylori infection 
negative 
(N) 
 
 
Ref. 
Genotype/Allele Genotype/Allele 
 
 
 
TLR1 
 
 
 
 
Ser248Asn 
(C→T) 
 
 
rs4833095 
CC CT TT C T CC CT TT C T  
629 660 199 NA NA 379 499 140 NA NA 12 
122 4 78 NA NA 14 182 0 NA NA 16 
23 19 15 NA NA 9 8 11 NA NA 18 
122 4 78 NA NA 14 182 0 NA NA 17 
Ile602Ser 
(I→S) 
 
rs5743618 
II IS SS I S II IS SS I S  
14 72 143 NA NA 4 17 32 NA NA 26 
 
 
 
 
 
 
 
TLR2 
  
 
 
 
-196 to -174  
(ins → del) 
 ins/ 
ins 
ins/ 
del 
del/ 
del 
ins del ins/ 
ins 
ins/ 
del 
del/ 
del 
ins del  
418 414 105 NA NA 304 316 79 NA NA 14 
81 90 19 252 128 46 39 6 131 51 13 
42 NA NA 93 17 26 NA NA 67 23 21 
T→C  
rs3804099 
TT TC CC T C TT TC CC T C  
126 27 51 NA NA 131 41 24 NA NA 16 
 
T→C 
 
rs3804100 
TT TC CC T C TT TC CC T C  
147 49 8 NA NA 149 43 4 NA NA 16 
+2251 
(G→A) 
 GG GA AA G A GG GA AA G A  
225 2 0 NA NA 252 4 0 NA NA 29 
Arg677Trp 
(C→T) 
 
rs121917864 
CC CT TT C T CC CT TT C T  
4 NA NA 58 52 3 NA NA 47 43 21 
Arg753Gln 
(G→A) 
 
rs5743708 
GG GA AA G A GG GA AA G A  
50 NA NA 102 8 44 NA NA 89 1 21 
 
 
 
 
 
 
 
 
 
 
 
TLR4 
 
 
 
 
 
Asp299Gly 
+896 
(A→G) 
 
 
 
rs4986790 
AA AG GG A G AA AG GG A G  
155 40 0 NA NA 194 37 2 NA NA 23 
86 18 0 NA NA 21 5 0 NA NA 20 
88 15 0 NA NA 42 4 0 NA NA 25 
524 69 1 NA NA 313 45 0 NA NA 27 
206 25 1 NA NA 222 28 4 NA NA 29 
45 25 7 115 39 189 38 3 416 44 19 
50 NA NA 106 6 41 NA NA 85 3 22 
Thr399Ile 
1196 
(C→T) 
rs4986791 CC CT TT C T CC CT TT C T  
93 11 0 NA NA 21 5 0 NA NA 20 
38 30 9 106 48 202 22 6 426 34 19 
49 NA NA 103 9 42 NA NA 86 2 22 
 
+3725  
(G→C) 
 
rs11536889 
GG GC CC G C GG GC CC G C  
627 474 90 NA NA 199 162 40 NA NA 15 
279 51 9 609 69 182 44 4 408 52 28 
110 62 10 282 82 50 36 3 136 42 13 
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37 NA NA 93 19 26 NA NA 70 18 22 
T→C 
 
rs10759932 
TT TC CC T C TT TC CC T C  
153 37 14 NA NA 139 53 4 NA NA 16 
C→T rs1927914 CC CT TT C T CC CT TT C T  
0 8 69 8 146 0 150 80 150 310 19 
TLR5 
 
+1174 
(C→T) 
rs5744168 
CC CT TT C T CC CT TT C T  
206 19 0 NA NA 239 16 0 NA NA 29 
 
 
 
TLR9 
 
C→T 
 
rs352140 
CC CT TT C T CC CT TT C T  
25 46 6 96 58 100 98 32 298 162 19 
 
C→T 
 
rs34399053 
CC CT TT C T CC CT TT C T  
26 51 0 103 51 79 150 1 308 152 19 
 
C→T 
 
rs150459369 
CC CT TT C T CC CT TT C T  
77 0 0 154 0 220 10 0 450 10 19 
-1237 
(T→C) 
 
rs5743836 
TT TC CC T C TT TC CC T C  
77 40 0 NA NA 35 15 1 NA NA 24 
 
 
TLR10 
 
 
 
C→T 
 
 
rs10004195 
AA AT TT A T AA AT TT A T  
498 712 276 NA NA 308 493 207 NA NA 12 
59 10 135 NA NA 22 123 51 NA NA 16 
24 18 15 NA NA 9 11 8 NA NA 18 
 
Ile775Val 
 
rs4129009 
TT TC CC T C TT TC CC T C  
507 715 275 NA NA 351 490 177 NA NA 12 
TLR= Toll-like receptor; SNP= Single nucleotide polymorphism; ins= Insertion, del= Deletion; NA= Not 
available 
 
Table 3. Association between polymorphisms in the TLRs genes, genotypes/alleles, and H. pylori infection 
Polymorphism Genotype/Allele Odds Ratio 95% CI P-
value  
I2 
(%) 
Effect 
model 
TLR1 rs4833095 C vs. T NA NA - - - 
 CC vs. TT 1.605 (0.485-5.309) 0.439 69.2 R 
 CC vs. CT 0.048 (0.002-1.247) 0.068 98.4 R 
TLR1 rs5743618 I vs. S NA NA - - - 
 II vs. SS 1.277 (0.394-4.136) 0.684 0.00 F 
 II vs. IS 1.210 (0.354-4.142) 0.304 0.00 F 
TLR2 -196 to -174 ins>del ins vs. del 0.876 (0.366-2.097) 0.766 79 R 
 ins/ins vs. del/del 1.028 (0.754-1.402) 0.862 27 F 
 ins/ins vs. ins/del 0.995 (0.821-1.208) 0.963 19.2 F 
TLR2 rs3804099 T vs. C NA NA - - - 
 TT vs. CC 2.209 (1.283-3.804) 0.004 0.00 F 
 TT vs. TC 0.685 (0.397-1.179) 0.172 0.00 F 
TLR2 rs3804100 T vs. C NA NA - - - 
 TT vs. CC 2.027 (0.597-6.878) 0.257 0.00 F 
 TT vs. TC 1.155 (0.723-1.846) 0.547 0.00 F 
TLR2 (+2251) G vs. A NA NA - - - 
 GG vs. AA - - - - - 
 GG vs. GA 0.560 (0.102-3.087) 0.506 0.00 F 
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TLR2 rs121917864 C vs. T 0.980 (0.561-1.712) 0.943 0.00 F 
 CC vs. TT NA NA - - - 
 CC vs. CT - - - - - 
TLR2 rs5743708 G vs. A 6.980 (0.856-56.901) 0.070 0.00 F 
 GG vs. AA NA NA - - - 
 GG vs. GA NA NA - - - 
TLR4 rs4986790 A vs. G 2.987 (1.899-4.697) 0.000 0.00 F 
 AA vs. GG 1.234 (0.148-10.261) 0.846 69.6 R 
 AA vs. AG 1.293 (0.887-1.884) 0.182 53.1 R 
TLR4 rs4986791 C vs. T 5.469 (3.432-8.713) 0.000 0.00 F 
 CC vs. TT 7.974 (2.682-23.706) 0.000 0.00 F 
 CC vs. CT 1.984 (0.144-27.401) 0.609 93.6 R 
TLR4 rs11536889 G vs. C 0.895 (0.688-1.165) 0.410 0.00 F 
 GG vs. CC 0.813 (0.562-1.175) 0.271 12.3 F 
 GG vs. GC 0.872 (0.717-1.060) 0.169 0.00 F 
TLR4 rs10759932 T vs. C NA NA - - - 
 TT vs. CC 3.180 (1.022-9.890) 0.040 0.00 F 
 TT vs. TC 0.634 (0.393-1.024) 0.062 0.00 F 
TLR4 rs1927914 C vs. T 8.831 (4.222-18.470) 0.000 0.00 F 
 CC vs. TT - - - - - 
 CC vs. CT - - - - - 
TLR5 rs5744168 C vs. T NA NA - - - 
 CC vs. TT - - - - - 
 CC vs. CT 1.378 (0.691-2.749) 0.363 0.00 F 
TLR9 rs352140 C vs. T 1.111 (0.762-1.622) 0.584 0.00 F 
 CC vs. TT 0.750 (0.283-1.990) 0.563 0.00 F 
 CC vs. CT 1.878 (1.071-3.290) 0.028 0.00 F 
TLR9 rs34399053 C vs. T 1.003 (0.681-1.479) 0.987 0.00 F 
 CC vs. TT 1.000 (0.040-25.296) 1.000 0.00 F 
 CC vs. CT 1.033 (0.599-1.782) 0.907 0.00 F 
TLR9 rs150459369 C vs. T 0.139 (0.008-2.383) 0.173 0.00 F 
 CC vs. TT - - - - - 
 CC vs. CT 0.135 (0.008-2.339) 0.169 0.00 F 
TLR9 rs5743836 T vs. C NA NA - - - 
 TT vs. CC 0.153 (0.006-3.841) 0.253 0.00 F 
 TT vs. TC 1.212 (0.593-2.479) 0.598 0.00 F 
TLR10 rs10004195 A vs. T NA NA - - - 
 AA vs. TT 0.839 (0.680-1.036) 0.102 0.00 F 
 AA vs. AT 0.258 (0.029-2.288) 0.224 96.8 R 
TLR10 rs4129009 T vs. C NA NA - - - 
 TT vs. CC 1.076 (0.852-1.358) 0.539 0.00 F 
 TT vs. TC 1.010 (0.845-1.207) 0.911 0.00 F 
Bold= Statistically significant result; R= Random-effect model; F= Fixed-effect model; CI= Confidence 
interval; NA= Not available 
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Discussion 
Genetic polymorphisms in TLRs, as key 
members of the innate immune system, mediate 
recognition of H. pylori and are assumed to 
play an important role in susceptibility to H. 
pylori infections [30]. However, there have 
been many conflicting reports concerning TLRs 
polymorphisms and their possible role in 
susceptibility to H. pylori infections. The 
current study is the first comprehensive 
systematic review and meta-analysis on the 
evaluation of association between TLR1, 2, 4, 
5, 9 and 10 polymorphisms with of H. pylori 
infection risk. TLR1 is a PRR which forms 
heterodimer with TLR2 and recognizes 
lipoprotein/lipopeptides of H. pylori [31]. 
Recently, several studies have shown that 
individuals carrying TLR1 rs4833095 CT and 
TT genotypes and T allele as well as TLR1 
rs5743618 SS genotype significantly decrease 
the risks of H. pylori infection and H. pylori-
related diseases [12, 26]. In the same manner, 
individuals carrying CC or TT homozygous 
genotypes are at increased risks [16-18]. 
However, in this study, the genotypic model 
failed to show any significant association 
between TLR1 rs4833095 and rs5743618 
polymorphisms with the susceptibility to H. 
pylori infections (Table 3). This difference may 
be due to the differences in ethnicities, 
assessment methods, population size and age. 
Another member of the PRRs is TLR2 which is 
implicated in the identification of Gram-
positive bacteria, mycobacteria, spirochetes, 
viruses, hepatitis C and B viruses, herpes 
simplex and cytomegalovirus, and fungi [31]. In 
the case of H. pylori, SNPs in genes that encode 
TLR2 are associated with H. pylori infection 
and H. pylori-related diseases. 
Our systematic review of included articles 
revealed that TLR2 -196 to 174del 
polymorphism is not significantly associated 
with H. pylori infection in the Japanese 
population [14]. However, increased risk of H. 
pylori-related diseases in H. pylori-infected 
individuals was observed in Chinese and 
Iranian populations carrying the above-
mentioned polymorphism [13, 21]. In this meta-
analysis, we could not detect any association 
between TLR2 -196 to 174del polymorphism 
and susceptibility to H. pylori infections (Table 
3). This difference may arise from variations in 
ethnicities. In the studies conducted in the Thai 
population, no significant association was 
discerned between TLR2 rs3804099 and 
rs3804100 polymorphisms with susceptibility 
to H. pylori infections [16]. However, we 
observed that individuals with the CC mutant 
homozygote genotype for TLR2 rs3804099 
bear a significantly increased risk of H. pylori 
infection (odds ratio = 2.209, 95% CI: 1.283-
3.804) (Table 3). In the Brazilian population, 
TLR2 (+2251) failed to project a significant 
association with susceptibility to H. pylori 
infections while in the Iranian population TLR2 
rs121917864 and rs5743708 proved significant 
associations with H. pylori infection [21, 29]. 
Our findings suggest that the TLR2 rs5743708 
A allele mutant was significantly associated 
with susceptibility to H. pylori infections (odds 
ratio = 6.980, 95% CI: 0.856-56.901) (Table 3). 
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TLR4 is located on the surface of immune cells 
such as monocytes, mast cells and neutrophils 
and, similar to TLR2, recognizes a wide 
number of endogenous ligands released during 
cellular stress and necrosis, and preserved 
microbial structures of Gram-negative bacteria 
[31). TLR4 expression increases during 
H. pylori infection on gastric epithelial cells and 
is the LPS receptor [31]. In the current meta-
analysis, five SNPs were found in the human 
TLR4 gene in H. pylori positive subjects.  
Whilst several studies with different population 
have reported that the TLR4 polymorphisms 
rs4986790, rs4986791, rs11536889, rs10759932 
and rs1927914 are either associated or not 
associated with the risk of H. pylori infection 
(Table 2), our study offers a significant 
association only with the TLR4 rs4986790 G 
mutant allele (odds ratio = 2.987, 95% CI: 
1.899-4.697), TLR4 rs4986791 TT mutant 
homozygote genotype (odds ratio = 7.974, 95% 
CI: 2.682-23.706) and T mutant allele (odds 
ratio = 5.469, 95% CI: 13.432-8.713), TLR4 
rs10759932 CC mutant genotype (odds ratio = 
3.180, 95% CI: 1.022-9.890) and TLR4 
rs1927914 T mutant allele (odds ratio = 8.831, 
95% CI: 4.222-18.470) and susceptibility to H. 
pylori infections (Table 3 and Fig. 2). 
Monomeric bacterial flagellin has the ability to 
stimulate innate immune responses mediated by 
TLR5 which is located on surface epithelial, 
and membrane of immune cells such as NK 
cells, monocytes and myeloid dendritic cells 
[31]. There are controversial studies on 
recognizing H. pylori flagellin by TLR5 and the 
association of TLR5 polymorphism and 
susceptibility to H. pylori infection [29]. In the 
current meta-analysis, there was no evidence 
linking TLR5 polymorphism and susceptibility 
to H. pylori infection. 
The plasmacytoid dendritic cells, B cells and 
NK cells express TLR9 which is involved in 
stimulating innate immune responses via 
detection of bacterial and viral unmethylated 
CpG DNA [31]. It has also been suggested  
that TLR9 rs352140 and s5743836 poly-
morphisms play a role in the susceptibility to H. 
pylori infection [19, 24]. Our results also 
demonstrated that TLR9 rs352140 CT mutant 
genotype conferred a significantly increased 
risk of H. pylori infections (odds ratio = 1.878, 
95% CI: 1.071-3.290) (Table 3 and Fig. 2). 
TLR10 is an anti-inflammatory PRR which is 
expressed in humans [12, 31]. Tang et al. [10], 
Simawaranon et al. [16], and Ram et al. [18] 
reported that TLR10 rs10004195 is associated 
with susceptibility to H. pylori infection in the 
Chinese, Thai and Malaysian population. 
However, no association was found between 
TLR10 polymorphisms and susceptibility to 
H. pylori infections in our study (Table 3). 
TLR11, TLR12 and TLR13 are expressed in 
mice but we could not find any study on  
the association of TLR3, 6-8 and 11-13 
polymorphisms and susceptibility to H. pylori 
infections. 
Conclusion  
This meta-analysis indicated that TLR2 
rs3804099, TLR4 rs4986790, TLR4 rs4986791, 
TLR4 rs10759932, TLR4 rs1927914 and TLR9 
rs352140 are associated with increased 
susceptibility to H. pylori infections. Possible 
reasons for discrepant findings in different 
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studies may be variances in population size, age 
and sex, ethnicity and race, methods of 
diagnosis of infection and genotyping, and 
differences in the prevalence of H. pylori 
infection. The results of this meta-analysis led 
to the widely accepted conclusion that H. pylori 
infections are associated with TLRs genetic 
variations. In conclusion, evidences support the 
important role of TLRs in H. pylori infection as 
these receptors of the innate immune system 
have been shown to recognize diverse 
components of H. pylori, the major risk factor 
for gastric cancer. Given that host genetic 
variability in the TLRs are known to be 
associated with an increased risk of H. pylori 
infection, this knowledge has the potential to 
allow better prevention of H. pylori infection 
and subsequently gastric cancer through 
selective treatment and surveillance of 
individuals harboring high risk genetic profiles. 
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